RG

Raghavendra Ganpatrao Manepure

Active Director Designated Partner DIN 07870851
DIN 07870851 First appointment Jul 2017 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Raghavendra Ganpatrao Manepure

Data last updated:

Raghavendra Ganpatrao Manepure is a Designated Partner at Qualifaith Pharma Llp (since 2017). The company operates in Business Services.

DIN 07870851
Primary Designation Designated Partner
Industry Business Services
First Appointment 28 Jul 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner28 Jul 20172017Active

Board colleagues of Raghavendra Ganpatrao Manepure

NameDINCompanyDesignation
Shital Vinay Dugad07870877Qualifaith Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Qualifaith Pharma Llp
Premium access

Shareholding and investment profile for Raghavendra Ganpatrao Manepure

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raghavendra Ganpatrao Manepure

Raghavendra Ganpatrao Manepure currently holds 1 directorship: Qualifaith Pharma Llp (Designated Partner, since 28 Jul 2017).

Raghavendra Ganpatrao Manepure was first appointed on 28 Jul 2017 as Designated Partner at Qualifaith Pharma Llp.

The current boards of Raghavendra Ganpatrao Manepure's companies include Shital Vinay Dugad (Qualifaith Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available